(Q42678485)

4 November 2017

The putative AMPA receptor antagonist, LY326325, produces anxiolytic-like effects without altering locomotor activity in rats (English)

1 reference

4 November 2017

Kotlinska J

1

1 reference

PubMed ID

9610933

4 November 2017

Liljequist S

series ordinal

2

1 reference

PubMed ID

9610933

4 November 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

Pharmacology, Biochemistry and Behavior

4 November 2017

1 reference

4 November 2017

60

1 reference

4 November 2017

119-124

1 reference

4 November 2017

1

1 reference

2-Amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepam.

4 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Effects of 5,7 dichlorokynurenic acid on conflict, social interaction and plus maze behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Effects of ethanol, chlordiazepoxide, and MK-801 on performance in the elevated-plus maze and on locomotor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Glutamate antagonists have different effects on spontaneous locomotor activity in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Use of the elevated plus maze in the search for novel anxiolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

The neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Cloned glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Evidence for an anxiogenic action of AMPA receptor antagonists in the plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Behavioral effects of non-NMDA glutamate receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Genetic differences in the effects of competitive and non-competitive NMDA receptor antagonists on locomotor activity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

The effects of GABA and benzodiazepine receptor antagonists on the anti-conflict actions of diazepam or ethanol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

A benzodiazepine antagonist action of CL 218,872

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Clinical experience with excitatory amino acid antagonist drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

(3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3 - carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Pro- and anti-convulsant drug effects in combination with the convulsant benzodiazepine Ro 5-4864.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Effects of antagonists at the NMDA receptor complex in two models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Anxiolytic-like and antinociceptive effects of MK-801 accompanied by sedation and ataxia in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Selective protection against AMPA- and kainate-evoked neurotoxicity by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisoquinoline- 3-carboxylic acid (LY293558) and its racemate (LY215490)

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

Anxiolytic-like effects of the noncompetitive NMDA antagonist MK 801

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900565-0

7 January 2021

10.1016/S0091-3057(97)00565-0

Identifiers

DOI

1 reference

4 November 2017

1 reference

PubMed ID

9610933